Literature DB >> 20534709

An enigmatic tail of CD28 signaling.

Jonathan S Boomer1, Jonathan M Green.   

Abstract

CD28 costimulation regulates a wide range of cellular processes, from proliferation and survival to promoting the differentiation of specialized T-cell subsets. Since first being identified over 20 years ago, CD28 has remained a subject of intense study because of its profound consequences on T cell function and its potential for therapeutic manipulation. In this review we highlight the signaling cascades initiated by the major signaling motifs in CD28, focusing on PI-3 kinase-dependent and -independent pathways and how these are linked to specific cellular outcomes. Recent studies using gene targeted knockin mice have clarified the relative importance of these motifs on in vivo immune responses; however, much remains to be elucidated. Understanding the mechanism behind costimulation holds great potential for development of new clinically relevant reagents, a fact beginning to be realized with the advent of drugs that prevent CD28 ligation and signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20534709      PMCID: PMC2908766          DOI: 10.1101/cshperspect.a002436

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  207 in total

1.  A point mutation in CD28 distinguishes proliferative signals from survival signals.

Authors:  K Okkenhaug; L Wu; K M Garza; J La Rose; W Khoo; B Odermatt; T W Mak; P S Ohashi; R Rottapel
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

2.  Three-dimensional segregation of supramolecular activation clusters in T cells.

Authors:  C R Monks; B A Freiberg; H Kupfer; N Sciaky; A Kupfer
Journal:  Nature       Date:  1998-09-03       Impact factor: 49.962

3.  ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28.

Authors:  A Hutloff; A M Dittrich; K C Beier; B Eljaschewitsch; R Kraft; I Anagnostopoulos; R A Kroczek
Journal:  Nature       Date:  1999-01-21       Impact factor: 49.962

4.  Cutting edge: distinct motifs within CD28 regulate T cell proliferation and induction of Bcl-XL.

Authors:  J S Burr; N D Savage; G E Messah; S L Kimzey; A S Shaw; R H Arch; J M Green
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

5.  Induction of NF-kappaB by the Akt/PKB kinase.

Authors:  L P Kane; V S Shapiro; D Stokoe; A Weiss
Journal:  Curr Biol       Date:  1999-06-03       Impact factor: 10.834

Review 6.  The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.

Authors:  S B Snapper; F S Rosen
Journal:  Annu Rev Immunol       Date:  1999       Impact factor: 28.527

7.  IkappaB kinases serve as a target of CD28 signaling.

Authors:  E W Harhaj; S C Sun
Journal:  J Biol Chem       Date:  1998-09-25       Impact factor: 5.157

8.  The proto-oncogene Cot kinase participates in CD3/CD28 induction of NF-kappaB acting through the NF-kappaB-inducing kinase and IkappaB kinases.

Authors:  X Lin; E T Cunningham; Y Mu; R Geleziunas; W C Greene
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

9.  Identification of tyrosine phosphorylation sites in the CD28 cytoplasmic domain and their role in the costimulation of Jurkat T cells.

Authors:  A Sadra; T Cinek; J L Arellano; J Shi; K E Truitt; J B Imboden
Journal:  J Immunol       Date:  1999-02-15       Impact factor: 5.422

10.  An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness.

Authors:  D L Mueller; M K Jenkins; R H Schwartz
Journal:  J Immunol       Date:  1989-04-15       Impact factor: 5.422

View more
  101 in total

1.  Complementary costimulation of human T-cell subpopulations by cluster of differentiation 28 (CD28) and CD81.

Authors:  Yael Sagi; Angela Landrigan; Ronald Levy; Shoshana Levy
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-17       Impact factor: 11.205

2.  Recurrent activating mutations of CD28 in peripheral T-cell lymphomas.

Authors:  J Rohr; S Guo; J Huo; A Bouska; C Lachel; Y Li; P D Simone; W Zhang; Q Gong; C Wang; A Cannon; T Heavican; A Mottok; S Hung; A Rosenwald; R Gascoyne; K Fu; T C Greiner; D D Weisenburger; J M Vose; L M Staudt; W Xiao; G E O Borgstahl; S Davis; C Steidl; T McKeithan; J Iqbal; W C Chan
Journal:  Leukemia       Date:  2015-12-31       Impact factor: 11.528

3.  Impaired NFAT and NFκB activation are involved in suppression of CD40 ligand expression by Δ(9)-tetrahydrocannabinol in human CD4(+) T cells.

Authors:  Thitirat Ngaotepprutaram; Barbara L F Kaplan; Norbert E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  2013-08-30       Impact factor: 4.219

4.  In the absence of its cytosolic domain, the CD28 molecule still contributes to T cell activation.

Authors:  Stéphanie O Morin; Valentin Giroux; Cédric Favre; Yassina Bechah; Nathalie Auphan-Anezin; Romain Roncagalli; Jean-Louis Mège; Daniel Olive; Marie Malissen; Jacques A Nunès
Journal:  Cell Mol Life Sci       Date:  2015-03-01       Impact factor: 9.261

Review 5.  Metabolic Barriers to T Cell Function in Tumors.

Authors:  Ayaka Sugiura; Jeffrey C Rathmell
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

6.  Functional analysis of acquired CD28 mutations identified in cutaneous T cell lymphoma.

Authors:  Grzegorz B Gmyrek; Jeanette Pingel; Jaehyuk Choi; Jonathan M Green
Journal:  Cell Immunol       Date:  2017-07-10       Impact factor: 4.868

Review 7.  Versatile CAR T-cells for cancer immunotherapy.

Authors:  Fuliang Chu; Jingjing Cao; Sattva S Neelalpu
Journal:  Contemp Oncol (Pozn)       Date:  2018-03-05

Review 8.  The promise and challenges of immune agonist antibody development in cancer.

Authors:  Patrick A Mayes; Kenneth W Hance; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2018-06-15       Impact factor: 84.694

Review 9.  CD28 Costimulation: From Mechanism to Therapy.

Authors:  Jonathan H Esensten; Ynes A Helou; Gaurav Chopra; Arthur Weiss; Jeffrey A Bluestone
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

10.  CD28 and CD3 have complementary roles in T-cell traction forces.

Authors:  Keenan T Bashour; Alexander Gondarenko; Haoqian Chen; Keyue Shen; Xin Liu; Morgan Huse; James C Hone; Lance C Kam
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.